AKTX Akari Therapeutics Plc: Sotuvning sof marjinal rentabelligi

Akari Therapeutics PLC (AKTX) grafik logotipi

Akari Therapeutics (AKTX) kamyob kasalliklarni davolash uchun Nomacopan maqsadli ingibitorlari ekotizimini ishlab chiqmoqda. Kompaniyaning savdo marjalari aksiyalar narxi va klinik sinovlar natijalari o'rtasidagi korrelyatsiyani namoyish etadi, 0.00 qiymati esa metrika darajasini qayd etadi. Muntazam pul oqimlarining yo'qligi va birlashishdan keyingi yuqori xarajatlar darajasi tijorat daromadlari erishilgunga qadar aktivlarning qiymati pasayishi xavflarini yuzaga keltirmoqda.

Akari Therapeutics, Plc (AKTX) Sof foyda normasi: 04.07.2022 - 20.11.2026 davri uchun

Akari Therapeutics (AKTX) - koʻrsatkichlar kesimi va moliyaviy hisobotlar

- bozor qiymati va tahlilchilarning maqsadli prognozi:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
Kompaniyaning fundamental baholanishi:Akari Therapeutics Plc - AKTX
Akari Therapeutics, Plc tayyor mahsulotlari

Akari Therapeutics (AKTX) kompaniyasining moslashuvchan modeli katta kapital xarajatlar yo'qligi sababli investorlarni jalb qilmoqda. Ushbu ko'rsatkich har bir dollar daromadning sof foyda ulushini belgilab, biznesning umumiy samaradorligini aks ettiradi. Mahsulotlar sotuvidan olingan sof foyda marjasining tahlili klinik sinovlar uchun autsorsing xarajatlarining yakuniy moliyaviy natijalarga qanday ta'sir qilishini baholash imkonini beradi. Ushbu ko'rsatkichning o'sishi operatsion xarajatlarning optimallashtirilganligini tasdiqlaydi. Barqaror ijobiy dinamika kompaniyaning fundamental barqarorligidan dalolat beradi.

Akari Therapeutics kimlar bilan raqobatlashadi

argenx (ARGX) - Sof marja|BNTX - Kompaniya sotuv marjasi|ABVX (Abivax Pharma) - Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi ADMA Bio (ADMA)|Sof foyda bo'yicha sotuv rentabelligi PTGX (Protagonist Therapeutics Inc)|Sotuvning sof marjinal rentabelligi immunovant.com (IMVT)|Sof marja kiniksa.com KNSA|Grifols SA (GRFS) - Sof marja|Adaptive Biotechnologies Inc. - Sotuvning sof marjinal rentabelligi|Sof marja Celldex Therapeutics|AUPH: Sotuvning sof marjinal rentabelligi|BCRX - Kompaniya sotuv marjasi|VERA (Vera Corp) - Sotuvning sof marjinal rentabelligi|Dianthus Pharma (DNTH) - Kompaniya sotuv marjasi|Sof marja Pharvaris Pharma (PHVS)|Sotuvning sof marjinal rentabelligi AbCellera Corp (ABCL)|Sotuvning sof marjinal rentabelligi TRML (Tourmaline Bio Inc)|Kompaniya sotuv marjasi precigen.com (PGEN)|PHAR - Sof marja|Sof foyda normasi NKTR (Nektar Therapeutics Inc.)|UPB (Upstream Bio Corp) - Sof foyda bo'yicha sotuv rentabelligi|Zenas Corp (ZBIO) - Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi IMNM|GOSS: Sof foyda normasi|Sof marja KalVista Pharma (KALV)|SEPN - Sof marja|Sotuvning sof marjinal rentabelligi PVLA (pieris.com)|Sotuvning sof marjinal rentabelligi Savara Pharma SVRA|RIGL: Sof foyda bo'yicha sotuv rentabelligi|ANAB - Sotuvning sof marjinal rentabelligi|ATXS: Sotuvning sof marjinal rentabelligi|ENGN - Kompaniya sotuv marjasi|Sof foyda bo'yicha sotuv rentabelligi RAPT|JBIO (Aerovate Therapeutics Inc) - Kompaniyaning sof rentabelligi|Sotuvning sof marjinal rentabelligi ACRS|Sof foyda bo'yicha sotuv rentabelligi kyvernatx.com KYTX|Sotuvning sof marjinal rentabelligi TLSA (Tiziana Life Sciences, Ltd.)|Sotuvning sof marjinal rentabelligi Cabaletta Bio CABA|VTYX: Sof foyda bo'yicha sotuv rentabelligi|Theratechnologies Inc. (THTX) - Sof foyda bo'yicha sotuv rentabelligi|AVTX: Sotuvning sof marjinal rentabelligi|ELDN - Kompaniya sotuv marjasi|AGEN (Agenus, Inc) - Sotuvning sof marjinal rentabelligi|Sotuvning sof marjinal rentabelligi Climb Bio, Inc.|Sof marja Zura Bio Limited (ZURA)|ATYR (aTyr Pharmaceuticals) - Sof foyda normasi|Sotuvning sof marjinal rentabelligi ADAG (Adagene Inc)|IMA - Sof foyda bo'yicha sotuv rentabelligi|STTK - Sof marja|EQ (equilliumbio.com) - Sotuvning sof rentabelligi|CNTB: Sotuvning sof marjinal rentabelligi|Immunic Inc (IMUX) - Sotuvning sof marjinal rentabelligi|ATRA (Atara Biotherapeutics Inc) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi IFRX (InflaRx N.V.)|x4pharma.com (XFOR) - Sof foyda normasi|Adicet Bio, Inc. - Sotuvning sof rentabelligi|Celularity Inc - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof marjinal rentabelligi INmune Bio Corporation INMB|Barinthus Biotherapeutics - Sotuvning sof marjinal rentabelligi|Kezar Life Sciences, Inc. (KZR) - Sof foyda bo'yicha sotuv rentabelligi|SAB Biotherapeutics Inc. (SABS) - Sof marja|ENLV - Kompaniya sotuv marjasi|QTTB (Q32 Bio) - Sotuvning sof marjinal rentabelligi|Sof marja GeoVax Labs Inc GOVX|Sof marja Edesa Biotech (EDSA)|Sof foyda bo'yicha sotuv rentabelligi iBio IBIO|Carisma Therapeutics Inc - Sof foyda bo'yicha sotuv rentabelligi|XTLB - Sof foyda bo'yicha sotuv rentabelligi|BOLT - Sof marja|Sof foyda normasi HCWB (hcwbiologics.com)|APVO: Sotuvning sof marjinal rentabelligi|aimimmuno.com (AIM) - Sotuvning sof marjinal rentabelligi|Sof marja aditxt.com|Sof foyda bo'yicha sotuv rentabelligi GRI Bio Corp (GRI)|Sof marja XORTX Therapeutics Inc. (XRTX)|Sof foyda bo'yicha sotuv rentabelligi ReShape Lifesciences HIND|Sof marja Revelation Biosciences REVB|INDP: Sotuvning sof rentabelligi|SCNI - Sof marja|CALI (calcimedica.com) - Sotuvning sof rentabelligi|AFMD (Affimed Therapeutics) - Sof foyda bo'yicha sotuv rentabelligi|Allakos Therapeutics (ALLK) - Sotuvning sof marjinal rentabelligi|HOOK (HOOKIPA) - Sotuvning sof marjinal rentabelligi|igmbio.com (IGMS) - Kompaniya sotuv marjasi|Sotuvning sof marjinal rentabelligi ITOS|OCEA (Ocean Biomedical) - Sof foyda normasi|Sotuvning sof marjinal rentabelligi TCBP (TC BioPharm (Holdings) PLC)|THRD - Sof foyda bo'yicha sotuv rentabelligi